Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.550
+0.380 (17.51%)
Feb 7, 2025, 4:00 PM EST - Market closed
Microbot Medical Market Cap
Microbot Medical has a market cap or net worth of $43.18 million as of February 7, 2025. Its market cap has increased by 185.94% in one year.
Market Cap
43.18M
Enterprise Value
38.93M
1-Year Change
185.94%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since December 1, 1998, Microbot Medical's market cap has increased from $25.90M to $43.18M, an increase of 66.71%. That is a compound annual growth rate of 1.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 6, 2025 | 36.70M | 93.16% |
Dec 31, 2024 | 19.00M | -1.04% |
Dec 29, 2023 | 19.20M | -19.33% |
Dec 30, 2022 | 23.80M | -55.35% |
Dec 31, 2021 | 53.30M | 8.78% |
Dec 31, 2020 | 49.00M | 11.87% |
Dec 31, 2019 | 43.80M | 758.82% |
Dec 31, 2018 | 5.10M | -87.06% |
Dec 29, 2017 | 39.40M | 258.18% |
Dec 30, 2016 | 11.00M | -75.72% |
Dec 31, 2015 | 45.30M | -29.77% |
Dec 31, 2014 | 64.50M | -4.59% |
Dec 31, 2013 | 67.60M | 10.82% |
Dec 31, 2012 | 61.00M | 416.95% |
Dec 30, 2011 | 11.80M | -91.40% |
Dec 31, 2010 | 137.20M | -7.98% |
Dec 31, 2009 | 149.10M | 35.05% |
Dec 31, 2008 | 110.40M | -8.76% |
Dec 31, 2007 | 121.00M | -41.32% |
Dec 29, 2006 | 206.20M | -7.62% |
Dec 30, 2005 | 223.20M | -2.75% |
Dec 31, 2004 | 229.50M | 242.54% |
Dec 31, 2003 | 67.00M | 130.24% |
Dec 31, 2002 | 29.10M | -64.47% |
Dec 31, 2001 | 81.90M | 56.90% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 791.07B |
UnitedHealth Group | 484.89B |
Novo Nordisk | 386.78B |
Johnson & Johnson | 368.73B |
AbbVie | 336.82B |
Abbott Laboratories | 224.61B |
AstraZeneca | 223.06B |
Merck & Co. | 220.79B |